Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06378177 |
| Consolidated Lead Sponsor | Lyvgen Biopharma Holdings Limited |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | ACTIVE NOT RECRUITING |
| Registered Enrollment | 64 participants (ESTIMATED) |
| Registered Start Date | 2024-06-21 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Beijing Cancer Hospital | Beijing, China | Open Hospital Dossier -> |
| Fujian Cancer Hospital | Fuzhou, China | Open Hospital Dossier -> |
| Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University | Guangzhou, China | Open Hospital Dossier -> |
| Guangxi Medical University Cancer Hospital | Nanning, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.